Four oral GLP-1R products in Phase III trials as race intensifies
GLP-1R injectable drugs are effective in treating obesity, but their success points to a gap in the market: oral alternatives.
Themes
‘Pill-on-a-thread’ cancer screening trial commences with first patients
Fasenra shows benefit in acute asthma and COPD in Phase II trial
Lead Gilead researcher highlights need for inclusive clinical trials for HIV
Amgen share price plummets despite Phase II weight loss success
Slope and LabConnect launch bidirectional API integration for clinical trial companies
Novotech report notes shift to adaptive designs in clinical trials
Dr Oz nominated to lead CMS despite big pharma ties
